Cargando…
Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer Patients
SIMPLE SUMMARY: Liquid biopsies offer the opportunity to monitor cancer progression and the response to treatment with a simple blood test. However, most of the technologies available analyze specific molecular alterations or require tumor tissue for analysis, which is very difficult to obtain in me...
Autores principales: | Aguilar-Mahecha, Adriana, Lafleur, Josiane, Brousse, Susie, Savichtcheva, Olga, Holden, Kimberly A., Faulkner, Nathan, McLennan, Graham, Jensen, Taylor J., Basik, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999382/ https://www.ncbi.nlm.nih.gov/pubmed/33809567 http://dx.doi.org/10.3390/cancers13061331 |
Ejemplares similares
-
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
por: Cavallone, Luca, et al.
Publicado: (2020) -
Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+ Gastric Cancer Patient: Case Report
por: Aguilar-Mahecha, Adriana, et al.
Publicado: (2019) -
A micro-flow, high-pH, reversed-phase peptide fractionation and collection system for targeted and in-depth proteomics of low-abundance proteins in limiting samples
por: Zurawska, Marta, et al.
Publicado: (2023) -
The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines
por: Aguilar-Mahecha, Adriana, et al.
Publicado: (2012) -
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker
por: Aguilar-Mahecha, Adriana, et al.
Publicado: (2009)